Recent Quotes (30 days)

You have no recent quotes
chg | %

Easton Pharmaceuticals Inc  

(Public, OTCMKTS:EAPH)   Watch this stock  
Find more results for EAPH
0.00000 (0.00%)
Nov 25 - Close
OTCMKTS data delayed by 15 mins - Disclaimer
Currency in USD
Range     -
52 week 0.00 - 0.04
Open     -
Vol / Avg. 0.00/1.25M
Mkt cap 3.25M
P/E     -
Div/yield     -
EPS 0.00
Shares 224.71M
Beta -10.05
Inst. own     -

Key stats and ratios

Q2 (Jun '13) 2012
Net profit margin - -
Operating margin - -
EBITD margin - -
Return on average assets -36.35% -29.33%
Return on average equity -239.86% -132.63%
Employees 5 -
CDP Score - -


12 Timber Creek Ln
NEWARK, DE 19711-2606
United States - Map
+1-302-7376260 (Phone)
+1-416-6461000 (Fax)

Website links


Easton Pharmaceuticals, Inc., formerly LAM Industries, Inc., is a development-stage company engaged in various pharmaceutical sectors and others industries, such as medical marijuana. The Company is the owner and developer of a transdermal delivery technology, Viorra Delivery Matrix (VDM). The Company owns topically-delivered drugs and therapeutic/cosmetic healthcare products focused on cancer and other health problems geared towards female sexual dysfunction, wound healing, pain, motion sickness and other conditions. The Company has ventured into the medical marijuana industry through an investment into AMFIL Technologies and their groZONE anti-bacterial system. The Company's products include Nauseasol, a motion sickness gel; Skin Renou HA, an anti-aging wrinkle cream; Kenestrin Gel, which is used for arthritis, knees, elbows, shoulders, wrist and back pain; Viorra, an aid to the relief of female sexual arousal disorder (FSAD); XILIVE, a cancer drug, and FSAD drug.

Officers and directors

John Adams President, Chief Executive Officer
Age: 53
Walter Folinski Chief Financial Officer
Neil Mellor Chief Operating Officer
Jack Barkin M.D. Senior Vice President, Chief Medical Officer
Susan Whyte Vice President - Marketing
John Mitchell Vice President - Business Development